Automation PLC Developer – Chicago (US)

About the role

We are looking for an experienced PLC Software Engineer to join our automation team in Elgin, IL. In this role, you will design, develop, and deploy advanced control systems software tailored for high-tech pharmaceutical manufacturing environments. If you thrive in solving complex technical challenges, working with cutting-edge mechatronics, and delivering reliable automated solutions, this is your opportunity to elevate your engineering career!

Responsibilities

• Program PLC software in Structured Text (ST) for Siemens and Rockwell platforms.
• Configure Siemens and Allen-Bradley inverters, FESTO motion systems, PILZ safety PLCs, and industrial communications.
• Setup and manage PROFINET/PROFIBUS networks, SCALANCE/STRATIX switches, and Secomea remote access routers.
• Lead internal testing, Factory Acceptance Testing (FAT), Site Acceptance Testing (SAT), and provide remote troubleshooting support.
• Translate functional specs into secure software architecture adhering to GAMP5 and GMP pharmaceutical standards.
• Occasional international travel (1 to 4 weeks per project across North America, South America, and Asia for FAT/SAT/Commissioning).

Qualifications & Experience

• 5+ years of total PLC software development experience + minimum 2 years dedicated to the pharmaceutical industry.
• Degree in Automation Engineering, Electrical Engineering, or equivalent technical background.
• Proven expertise in Siemens (TIA Portal) and Rockwell (Logix) using Structured Text, Visual Studio, and electrical schematic reading.
• Familiarity with scripting (Bash/PowerShell) or software version control tools (preferred).
• Strong problem-solving mindset, high autonomy in project execution, and ability to collaborate across international teams.
• Valid US Driver’s License and US Passport for international travel.

Benefits

• Full health coverage provided (either via comprehensive medical insurance or an added value allowance).

Pay

Base Salary Range: $110,000 – $130,000 / year (Full-time, Exempt)

Target Start Date

November 2026